Close
The National Institutes of Health researchers have recently isolated a set of potential and tiny antibodies, also called nanobodies as shields from SARS-CoV-2, reportedly produced by a llama Cormac.
Initial findings published in Scientific Reports suggest that at least one of the said nanobodies, also known as NIH-CoVnb-112, could prevent infections and identify virus particles by grabbing hold of SARS-CoV-2 spike proteins.
Additionally, the nanobody seemed effective equally well in either aerosol or liquid form, suggesting it could stay effective following inhalation. SARS-CoV-2 is a virus that causes COVID-19.
The research, led by two neuroscientists, Thomas J. or TJ Esparza, BS, and David Brody, MD, Ph.D., is working in a brain imaging laboratory at the National Institute of Neurological Disorders Stroke or NIND of the NIH.